LRF Antagonists
AssigneeThe Salk Institute for Biological Studies
InventorsJean E. F. Rivier, Catherine L. Rivier, Wylie W. Vale, Jr.
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Salk Institute for Biological Studies
InventorsJean E. F. Rivier, Catherine L. Rivier, Wylie W. Vale, Jr.
Estimating the term…
Peptides which inhibit the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. Administration of an effective amount prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads. The peptides have the structure: R.sub.1 -R.sub.2 -R.sub.3 -Ser-Tyr-R.sub.4 -R.sub.5 -Arg-R.sub.6 wherein R.sub.1 is selected from the group consisting of dehydro Pro, dehydro D-Pro, Acetyl dehydro Pro and acetyl dehydro D-Pro; R.sub.2 is selected from the group consisting of D-Phe, Phe, N.alpha.Me-Phe, His, D-His, D-Trp, Trp and N.alpha.Me-Leu; R.sub.3 is selected from the group consisting of D-Trp, Trp D-Phe, Phe, Pro and D-His; R.sub.4 is selected from the group consisting of Gly, D-Trp, D-Phe, imBzl-D-His and D-Tyr; R.sub.5 is selected from the group consisting of Leu and N.alpha.Me-Leu; and R.sub.6 is selected from the group consisting of Pro-Gly-NH.sub.2 and Pro-NH-CH.sub.2 -CH.sub.3.
A method for preventing ovulation of female mammalian eggs or inhibiting the release of steroids by the gonads of a mammal comprising administering an effective amount of a peptide or a nontoxic salt thereof to a mammal, said peptide having the formula
A peptide having the formula R.sub.1 -R.sub.2 -R.sub.3 -Ser-Tyr-R.sub.4 -R.sub.5 Arg-R.sub.6 wherein R.sub.1 is selected from the group consisting of dehydro Pro, dehydro D-Pro, acetyl dehydro Pro and acetyl dehydro D-Pro;
A peptide having the formula R.sub.1 -D-Phe-D-Trp-Ser-Tyr-D-Trp-R.sub.5 -Arg-R.sub.6 wherein R.sub.1 is selected from the group consisting of dehydro Pro, dehydro D-Pro, acetyl dehydro Pro and acetyl dehydro D-Pro;
Dependencies are inferred from the claim text.